When a university Technology Transfer Office identifies a commercially viable piece of scientific instrumentation, the institutional reflex is almost always the same: incorporate a spin-off company.
The TTO drafts articles of incorporation. The PI is named as a founder, typically alongside one or two postdocs. A licensing agreement is negotiated—often an exclusive, worldwide license in exchange for equity and future royalties. The new entity is then pointed toward the venture capital ecosystem and told to raise a seed round.
For software innovations with massive addressable markets, this playbook can work. For niche scientific hardware that might sell 30–80 units per year, it is a structural trap. The spin-off model imposes an enormous overhead of corporate administration, fundraising, and CEO responsibilities onto researchers whose unique value lies in their scientific and engineering expertise. (For a deeper analysis of why the VC-backed spin-off model fails niche hardware, see The Startup Trap.)
There is a better model. It is called an asset carve-out, and it fundamentally changes the economics and risk profile of university IP licensing for hardware.
The Spin-off Overhead Problem
To understand why spin-offs fail for niche hardware, examine the cost structure.
A newly incorporated hardware spin-off must immediately fund:
- Corporate infrastructure: Office space, legal entity maintenance, accounting, insurance, and employer obligations under Dutch or European labor law
- Hiring: At minimum, a CEO (often the PI, reluctantly), a business development lead, and additional engineering capacity
- Redundant R&D: The new company must independently engineer a commercial enclosure, write a software stack, navigate CE marking, and establish manufacturing supply chains—all from scratch
- Fundraising overhead: Pitching to investors, negotiating term sheets, producing financial projections for a market that defies standard SaaS metrics
Before the spin-off has sold a single instrument, it has consumed €200k–€500k in structural overhead. For a niche product with €15k–€40k unit economics and a 40-unit annual market, the math is fatal. The company needs years of cash-burning operations before it can reach break-even—if it ever does.
The PI, meanwhile, has been transformed from a world-class optical engineer into a distressed startup CEO managing payroll and investor relations.
What is an Asset Carve-Out?
An asset carve-out separates the intellectual property from the individual. Instead of licensing the IP to a new, founder-dependent company, the TTO licenses the specific technology—the patent, the know-how, the prototype specifications—directly to an established execution partner.
The critical distinction is structural: the execution partner is not a startup. It is an existing entity with a proven track record in industrializing scientific hardware. It already possesses the commercial infrastructure—the engineering team, the manufacturing supply chain, the software architecture, the regulatory compliance framework—that the spin-off would have to build from zero. This is the operational model we describe in detail in The Valorisation-as-a-Service Framework.
Under an asset carve-out, the TTO negotiates a licensing agreement with the execution partner. The agreement defines:
- Scope: The specific technology and field of use being licensed
- Financial terms: A combination of upfront fees, royalties on unit sales, and/or milestone-based payments
- Performance obligations: Defined commercialization milestones (e.g., "Serial #001 deployed within 12 months") that ensure the IP does not sit dormant
- Reversion clauses: If the execution partner fails to meet milestones, the license reverts to the university
The PI does not become a CEO. The PI provides the scientific validation, participates in the engineering integration as a technical advisor (often compensated through a consulting agreement or a continued academic position), and retains academic freedom to continue their research program.
The Financial Mechanics
For TTOs evaluating deep tech tech transfer structures, the financial comparison between a spin-off and an asset carve-out is stark.
Spin-off model: The TTO receives equity (typically 5–15%) in a new company with no revenue, no infrastructure, and a high probability of failure. The expected value of this equity, discounted for the ~90% failure rate of deep tech hardware startups, is often close to zero. Royalty income depends entirely on the spin-off surviving long enough to generate sales.
Asset carve-out model: The TTO receives a licensing fee and royalties from an established entity that already has the infrastructure to produce and sell the instrument. Revenue begins when "Serial #001" ships—not when the company achieves profitability. The execution risk is fundamentally lower because the licensee is not building corporate infrastructure; it is adding a product line to an existing operation.
Frameworks such as the 4TU.CRIS deal terms or standard WIPO licensing templates provide well-established precedents for structuring these agreements. The negotiation is faster, the legal costs are lower, and the outcome is more predictable. For practical guidance on structuring the initial budget within this framework, see How to Budget an NWO Take-off Grant for Physical Hardware.
Protecting the Researcher
Beyond financial mechanics, the asset carve-out model addresses the most human dimension of tech transfer: it protects the researcher.
The spin-off model asks PIs to assume enormous personal risk. They must leave secure academic positions, sacrifice publishing output during critical career stages, and navigate a startup ecosystem that is structurally hostile to niche hardware. When the spin-off fails—as most do—the PI has lost years of academic productivity and often re-enters the research community with diminished momentum. We examine this dynamic in depth in The Hidden Career Cost of the Academic Spin-off.
The carve-out model preserves the PI's academic trajectory. Their invention reaches the market through a professional execution partner. They retain authorship of the underlying science. They can continue to publish, supervise PhD candidates, and pursue their next research breakthrough—all while receiving royalty income from a commercialized product carrying their name.
For TTOs whose mandate is to maximize the impact of academic research, the asset carve-out is not a compromise. It is a structurally superior mechanism for getting niche scientific hardware from the lab bench to the global market. At the ecosystem level, this model is also critical for retaining deep tech engineering talent that would otherwise leave hardware entirely.